Amplify Samsung SOFR ETF (SOFR)

100.38 -0.08%
Open in Risen →

Amplify Samsung SOFR ETF (SOFR) is an exchange-traded fund trading on NYSE Arca in Index and Sector ETFs. It is $100.38, -0.08%. RSI is 51.5, neutral. The fund has AUM of $4.2M and largest holding Novo Nordisk A/S at 11.9%.

Technical Analysis

RSI (14) 51.5 Neutral
Volume 1.5K

ETF Profile

AUM $4.2M
Expense Ratio 0.25%
Holdings 21

Top Holdings

Name Weight Value
Novo Nordisk A/S 11.89% $493,589
ELI LILLY AND COMPANY 11.56% $480,119
REGENERON PHARMACEUTICALS, INC. 6.77% $281,240
AMGEN INC. 6.27% $260,369
CHUGAI PHARMACEUTICAL CO., LTD. 6.00% $248,982
CSPC PHARMACEUTICAL GROUP LIMITED 5.03% $208,923
Arrowhead Pharmaceuticals Inc 4.96% $206,094
ABBVIE INC. 4.75% $197,263
ASTRAZENECA PLC 4.66% $193,275
PFIZER INC. 4.62% $191,730

Other Index and Sector ETFs

Ticker Price RSI Mkt Cap
SPY State Street SPDR S&P 500 ETF Trust $769.28 58.6 --
QQQ Invesco QQQ Trust, Series 1 $716.44 53.2 --
VOO Vanguard S&P 500 ETF $707.16 58.7 --

Take SOFR further

Set alerts on SOFR

Get notified when Amplify Samsung SOFR ETF hits your price targets or technical conditions are met.

Get Started Free